Abstract
Background. Clear cell renal cell carcinoma (ccRCC) is a renal cortical malignancy with a complex pathogenesis. Identifying ideal biomarkers to establish more accurate promising prognostic models is crucial for the survival of kidney cancer patients. Methods. Seurat R package was used for single‐cell RNA‐sequencing (scRNA‐seq) data filtering, dimensionality reduction, clustering, and differentially expressed genes analysis. Gene coexpression network analysis (WGCNA) was performed to identify the cytotoxicity‐related module. The independent cytotoxicity‐related risk model was established by the survival R package, and Kaplan–Meier (KM) survival analysis and timeROC with area under the curve (AUC) were employed to confirm the prognosis and effectiveness of the risk model. The risk and prognosis in patients suffering from ccRCC were predicted by establishing a nomogram. A comparison of the level of immune infiltration in different risk groups and subtypes using the CIBERSORT, MCP‐counter, and TIMER methods, as well as assessment of drug sensitivity to conventional chemotherapeutic agents in risk groups using the pRRophetic package, was made. Results. Eleven ccRCC subpopulations were identified by single‐cell sequencing data from the GSE224630 dataset. The identified cytotoxicity‐related T‐cell cluster and module genes defined three cytotoxicity‐related molecular subtypes. Six key genes (SOWAHB, SLC16A12, IL20RB, SLC12A8, PLG, and HHLA2) affecting prognosis risk genes were selected for developing a risk model. A nomogram containing the RiskScore and stage revealed that the RiskScore contributed the most and exhibited excellent predicted performance for prognosis in the calibration plots and decision curve analysis (DCA). Notably, high‐risk patients with ccRCC demonstrate a poorer prognosis with higher immune infiltration characteristics and TIDE scores, whereas low‐risk patients are more likely to benefit from immunotherapy. Conclusions. A ccRCC survival prognostic model was produced based on the cytotoxicity‐related signature, which had important clinical significance and may provide guidance for ccRCC treatment.